FDA inspection
Everest Life Sciences LLC: FDA inspection ending Oct 23, 2018
FDA inspection 1071273 · Voluntary Action Indicated (VAI) · Plainsboro, NJ
Key facts
| Inspection ID | 1071273 |
|---|---|
| Firm | Everest Life Sciences LLC |
| FEI number | 2243092 |
| Address | Industrial Research Laboratory Building, 31 Schalks Crossing Rd |
| City | Plainsboro |
| State | NJ |
| ZIP | 08536 |
| Country | United States |
| Fiscal year | 2019 |
| Inspection end date | Oct 23, 2018 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data